chemotherapy response

Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results
Steffen Böhm, Nhu Le, Michelle Lockley, Elly Brockbank, Asma Faruqi, Ian Said, Arjun Jeyarajah, Rekha Wuntakal, Blake Gilks, Naveena Singh

International Journal of Gynecologic Cancer Feb 2019, 29 (2) 353-356; DOI: 10.1136/ijgc-2018-000092
Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer
Hans-Christian Bösmüller, Philipp Wagner, Janet Kerstin Peper, Heiko Schuster, Deborah Lam Pham, Karen Greif, Christine Beschorner, Hans-Georg Rammensee, Stefan Stevanović, Falko Fend, Annette Staebler

International Journal of Gynecologic Cancer May 2016, 26 (4) 671-679; DOI: 10.1097/IGC.0000000000000672
Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum
M. Look, D. Chang, P. H. Sugarbaker

International Journal of Gynecologic Cancer Jan 2004, 14 (1) 35-41; DOI: 10.1136/ijgc-00009577-200401000-00004
Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum
M. Look, D. Chang, P. H. Sugarbaker

International Journal of Gynecologic Cancer Oct 2003, 13 (6) 764-770; DOI: 10.1136/ijgc-00009577-200311000-00006

Main menu